Evidence map›Paper›PMID 26762506›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2017

Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin.

C Daniel De Magalhaes Filho, Laurent Kappeler, Joëlle Dupont, Julien Solinc, Sonia Villapol, Cécile Denis, Marika Nosten-Bertrand, Jean-Marie Billard, Annick Blaise, François Tronche and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Insulin- Like Growth Factor-1 as Brain-Body Connector.Advances in experimental medicine and biology · 2025
    Review
  3. A role for astrocytic insulin-like growth factor I receptors in the response to ischemic insult.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society · 2018
    Observational
  17. Review
  18. Review
  19. Is Immunomodulation a Principal Mechanism Underlying How Cell-Based Therapies Enhance Stroke Recovery?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

C Daniel De Magalhaes Filho1 INSERM Research Center UMR938, Paris, France.
Laurent Kappeler1 INSERM Research Center UMR938, Paris, France.
Joëlle Dupont3 INRA UMR85, Nouzilly, France.
Julien Solinc1 INSERM Research Center UMR938, Paris, France.
Sonia Villapol4 INSERM U1141, Paris, France.
Cécile Denis2 Sorbonne Universités, UPMC - Université Pierre et Marie Curie, Paris, France.
Marika Nosten-Bertrand2 Sorbonne Universités, UPMC - Université Pierre et Marie Curie, Paris, France.
Jean-Marie Billard7 Centre de Psychiatrie et Neurosciences, UMR894, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Annick Blaise1 INSERM Research Center UMR938, Paris, France.
François Tronche2 Sorbonne Universités, UPMC - Université Pierre et Marie Curie, Paris, France.
Bruno Giros2 Sorbonne Universités, UPMC - Université Pierre et Marie Curie, Paris, France.
Christiane Charriaut-Marlangue4 INSERM U1141, Paris, France.
Saba Aïd1 INSERM Research Center UMR938, Paris, France.
Yves Le Bouc1 INSERM Research Center UMR938, Paris, France.
Martin Holzenberger1 INSERM Research Center UMR938, Paris, France.
Inserm · FRCentre National de la Recherche Scientifique · FRSorbonne Université · FRBiologie des Oiseaux et Aviculture · FRInstitut de Biologie Paris-Seine · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin-like growth factors control numerous processes, namely somatic growth, metabolism and stress resistance, connecting this pathway to aging and age-related diseases. Insulin-like growth factor signaling also impacts on neurogenesis, neuronal survival and structural plasticity. Recent reports demonstrated that diminished insulin-like growth factor signaling confers increased stress resistance in brain and other tissues. To better understand the role of neuronal insulin-like growth factor signaling in neuroprotection, we inactivated insulin-like growth factor type-1-receptor in forebrain neurons using conditional Cre-LoxP-mediated gene targeting. We found that brain structure and function, including memory performance, were preserved in insulin-like growth factor receptor mutants, and that certain characteristics improved, notably synaptic transmission in hippocampal neurons. To reveal stress-related roles of insulin-like growth factor signaling, we challenged the brain using a stroke-like insult. Importantly, when charged with hypoxia-ischemia, mutant brains were broadly protected from cell damage, neuroinflammation and cerebral edema. We also found that in mice with insulin-like growth factor receptor knockout specifically in forebrain neurons, a substantial systemic upregulation of growth hormone and insulin-like growth factor-I occurred, which was associated with significant somatic overgrowth. Collectively, we found strong evidence that blocking neuronal insulin-like growth factor signaling increases peripheral somatotropic tone and simultaneously protects the brain against hypoxic-ischemic injury, findings that may contribute to developing new therapeutic concepts preventing the disabling consequences of stroke.

Indexed as

Gene DeletionNeuroprotectionAnimalsFemaleGrowth HormoneMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsProsencephalonReceptor, IGF Type 1StrokeUp-RegulationGrowth HormoneReceptor, IGF Type 1Cerebral edemahypoxia-ischemiainsulin-like growth factorneuroinflammationneuroprotection

Identifiers

PMID26762506
PMCPMC5381438
OpenAlexW2269891609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.